According to CoinMeta, on November 5th, the project "Exploration of the Safety and Feasibility of scs Combined Non-invasive Brain-Controlled Hybrid Exoskeleton Training for the Treatment of Chronic Stroke-Induced Lower Limb Motor Disorders" officially completed the clinical research registration with the National Health Commission. This is the first non-invasive brain-computer interface (BCI) clinical research project in China to complete registration since the implementation of the "Regulations on the Management of Clinical Research and Translational Applications of New Biomedical Technologies" in May 2026, marking a new phase of standardized clinical research for China's cutting-edge non-invasive BCI technology. The core equipment used in this project is the "Shenggong-Shenchi," the world's first high-performance neuroregulation rehabilitation system for brain-spine-body integration, developed by the Brain-Computer Hahe Laboratory team. It is primarily used for neurorehabilitation intervention treatment of patients with chronic stroke-induced lower limb motor disorders during the platform stage.